A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus

被引:10
作者
Allen, E
Farewell, VT
Isenberg, DA
Gordon, C
机构
[1] UCL, Dept Stat Sci, London W1N 8AA, England
[2] Univ Cambridge, MRC, Biostat Unit, Cambridge CB2 1TN, England
[3] Middlesex Hosp, Dept Med, Ctr Rheumatol, London, England
[4] Univ Birmingham, Sch Med, Div Immun & Infect, Dept Rheumatol, Birmingham B15 2TT, W Midlands, England
关键词
systemic lupus erythematosus; renal disease; musculoskeletal disease; mucocutaneous disease;
D O I
10.1093/rheumatology/kei150
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To develop models for disease activity in patients with systemic lupus erythematosus (SLE) and to examine the hypothesis that possible subsets exist within the disease, notably renal disease and little else, mucocutaneous and musculoskeletal disease in isolation and more multisystem disease. Methods. Four hundred and forty patients with SLE were followed for a period of 10 yr. Socio-demographic data were obtained at the first visit with disease activity being recorded at subsequent visits and damage scores at 6-monthly intervals. Prognostic factors for active disease in each of the mucocutaneous, musculoskeletal and renal systems were examined statistically. The results were then validated using data collected over 5 yr on a further 295 SLE patients from a different centre. Results. Logistic regression analyses indicated that for all three systems studied a patient known to have an involvement in that system is more likely to present with active disease in that same system than a patient with no known prior involvement. Patients with a higher frequency of clinic visits with active disease in a system are more likely to represent with active disease than those with fewer visits. The results suggest that renal disease is most likely to occur on its own. Associations between activity in the mucocutaneous and musculoskeletal systems support the suggestion that patients with musculoskeletal and mucocutaneous disease alone represent a possible subset of SLE. None of the associations identified were modified by the medication a patient received. Conclusions. Previous disease history and involvement of other systems determine a patient's chance of developing further episodes of active disease in SLE.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 18 条
[1]  
ALLEN E, 2003, THESIS U LONDON, P96
[2]  
Chang ER, 2002, J RHEUMATOL, V29, P2350
[3]   Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus - Why some tests fail [J].
Esdaile, JM ;
Abrahamowicz, M ;
Joseph, L ;
MacKenzie, T ;
Li, Y ;
Danoff, D .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :370-378
[4]  
ESDAILE JM, 1996, J RHEUMATOL, V23, P1842
[5]   The reliability of the systemic Lupus International Collaborating Clinics American College of Rheumatology Damage Index in patients with Systemic Lupus Erythematosus [J].
Gladman, DD ;
Urowitz, MB ;
Goldsmith, CH ;
Fortin, P ;
Ginzler, E ;
Gordon, C ;
Hanly, JG ;
Isenberg, DA ;
Kalunian, K ;
Nived, O ;
Petri, M ;
SanchezGuerrero, J ;
Snaith, M ;
Sturfelt, G .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :809-813
[6]  
GLADMAN DD, 1992, J RHEUMATOL, V19, P608
[7]   Definition and treatment of lupus flares measured by the BILAG index [J].
Gordon, C ;
Sutcliffe, N ;
Skan, J ;
Stoll, T ;
Isenberg, DA .
RHEUMATOLOGY, 2003, 42 (11) :1372-1379
[8]  
HAY EM, 1993, Q J MED, V86, P447
[9]  
Ho A, 2001, ARTHRITIS RHEUM-US, V44, P2350, DOI 10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO
[10]  
2-A